Jump to full article: Canada Newswire (CNW) (ca), 2001-11-19
Intro: The first national program in North America to address the education needs of patients suffering from COPD (Chronic Obstructive Pulmonary Disease) will be launched at The Michener Institute for Applied Health Sciences on Monday, November 19, 2001 at 11:45 a.m. COPD is a major cause of chronic morbidity and mortality worldwide. The disease is increasing in prevalence and is expected to be the third leading cause of death in the world by 2020. An estimated 750,000 Canadians are affected (a four-fold increase since 1971). This program has been developed through a unique collaboration of international and national private and public sector organizations. The partners include:
The Canadian and Ontario Lung Associations
The Michener Institute for Applied Health Sciences
AstraZeneca (Canada Inc)
Boehringer Ingelheim (Canada) Ltd
GlaxoSmithKline (Canada) Inc
Jump to full article » |